Variation in hospital admission in febrile children evaluated at the Emergency Department (ED) in Europe: PERFORM, a multicentre prospective observational study.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 31 08 2020
accepted: 16 12 2020
entrez: 7 1 2021
pubmed: 8 1 2021
medline: 11 5 2021
Statut: epublish

Résumé

Hospitalisation is frequently used as a marker of disease severity in observational Emergency Department (ED) studies. The comparison of ED admission rates is complex in potentially being influenced by the characteristics of the region, ED, physician and patient. We aimed to study variation in ED admission rates of febrile children, to assess whether variation could be explained by disease severity and to identify patient groups with large variation, in order to use this to reduce unnecessary health care utilization that is often due to practice variation. MOFICHE (Management and Outcome of Fever in children in Europe, part of the PERFORM study, www.perform2020.org), is a prospective cohort study using routinely collected data on febrile children regarding patient characteristics (age, referral, vital signs and clinical alarming signs), diagnostic tests, therapy, diagnosis and hospital admission. Data were collected on febrile children aged 0-18 years presenting to 12 European EDs (2017-2018). We compared admission rates between EDs by using standardised admission rates after adjusting for patient characteristics and initiated tests at the ED, where standardised rates >1 demonstrate higher admission rates than expected and rates <1 indicate lower rates than expected based on the ED patient population. We included 38,120 children. Of those, 9.695 (25.4%) were admitted to a general ward (range EDs 5.1-54.5%). Adjusted standardised admission rates ranged between 0.6 and 1.5. The largest variation was seen in short admission rates (0.1-5.0), PICU admission rates (0.2-2.2), upper respiratory tract infections (0.4-1.7) and fever without focus (0.5-2.7). Variation was small in sepsis/meningitis (0.9-1.1). Large variation exists in admission rates of febrile children evaluated at European EDs, however, this variation is largely reduced after correcting for patient characteristics and therefore overall admission rates seem to adequately reflect disease severity or a potential for a severe disease course. However, for certain patient groups variation remains high even after adjusting for patient characteristics.

Identifiants

pubmed: 33411810
doi: 10.1371/journal.pone.0244810
pii: PONE-D-20-27296
pmc: PMC7790386
doi:

Types de publication

Journal Article Multicenter Study Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0244810

Subventions

Organisme : Department of Health
ID : CL-2018-21-007
Pays : United Kingdom

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Emerg Med J. 2016 May;33(5):329-37
pubmed: 26531861
Pediatrics. 2014 Sep;134(3):539-45
pubmed: 25113291
Am J Emerg Med. 2006 Nov;24(7):818-21
pubmed: 17098104
Arch Dis Child. 2019 Sep;104(9):869-873
pubmed: 31023707
QJM. 2016 Oct;109(10):675-680
pubmed: 27118873
PLoS One. 2017 Feb 2;12(2):e0170811
pubmed: 28151987
Pediatrics. 2013 Aug;132(2):369-70
pubmed: 23878042
Ann Emerg Med. 2013 Jan;61(1):27-32.e3
pubmed: 22841173
Glob Pediatr Health. 2019 Jul 25;6:2333794X19865447
pubmed: 31384632
PLoS Med. 2020 Aug 19;17(8):e1003208
pubmed: 32813708
Arch Dis Child. 2013 Jan;98(1):57-9
pubmed: 23220210
Intensive Crit Care Nurs. 2002 Jun;18(3):151-61
pubmed: 12405270
Arch Dis Child. 2020 Jul;105(7):661-663
pubmed: 31937571
Lancet Child Adolesc Health. 2020 Aug;4(8):583-591
pubmed: 32710839
Crit Care. 2018 May 31;22(1):143
pubmed: 29855385
Emerg Med J. 2012 May;29(5):379-82
pubmed: 21609944
Acad Emerg Med. 2014 Nov;21(11):1249-56
pubmed: 25377402
Pediatr Nurs. 2015 Nov-Dec;41(6):285-94
pubmed: 26837098
JAMA Pediatr. 2015 Sep;169(9):846-54
pubmed: 26192102
BMJ. 2017 Oct 25;359:j4857
pubmed: 29070598
Ann Am Thorac Soc. 2016 Jul;13(7):1081-8
pubmed: 27144510
Lancet Child Adolesc Health. 2018 Jun;2(6):404-414
pubmed: 30169282
JAMA. 2016 Aug 23-30;316(8):835-45
pubmed: 27552617
Emerg Med Int. 2014;2014:702053
pubmed: 24982807
J Emerg Med. 2019 Jun;56(6):583-591
pubmed: 31014970
BMJ Paediatr Open. 2019 Jun 27;3(1):e000456
pubmed: 31338429
Pediatr Emerg Care. 2016 Oct;32(10):664-668
pubmed: 25822238
BMC Med. 2019 Mar 6;17(1):48
pubmed: 30836976
Am J Emerg Med. 2020 Apr;38(4):774-779
pubmed: 31288959
Pediatr Emerg Care. 2017 Apr;33(4):278-286
pubmed: 28355170
Pediatr Emerg Care. 2001 Oct;17(5):321-3
pubmed: 11673706
Pediatr Emerg Care. 2015 Sep;31(9):633-9
pubmed: 26181498
BMJ Qual Saf. 2018 Jul;27(7):521-528
pubmed: 28971883
Pediatrics. 2009 Aug;124(2):439-45
pubmed: 19620201
Pediatr Emerg Care. 2005 Dec;21(12):816-21
pubmed: 16340756
Hosp Pediatr. 2016 Dec;6(12):714-721
pubmed: 27899409
J Matern Fetal Neonatal Med. 2016;29(13):2186-93
pubmed: 26365531
Pediatrics. 2017 May;139(5):
pubmed: 28557729
Influenza Other Respir Viruses. 2017 Nov;11(6):479-488
pubmed: 28872776
Crit Care. 2009;13(4):R135
pubmed: 19678924
Pediatrics. 2014 Feb;133(2):187-95
pubmed: 24470644

Auteurs

Dorine M Borensztajn (DM)

Department of General Paediatrics, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands.

Nienke N Hagedoorn (NN)

Department of General Paediatrics, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands.

Irene Rivero Calle (I)

Genetics, Vaccines, Infections and Pediatrics Research Group (GENVIP), Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain.

Ian K Maconochie (IK)

Section of Paediatric Infectious Diseases, Imperial College of Science, Technology and Medicine, London, United Kingdom.

Ulrich von Both (U)

Division of Paediatric Infectious Diseases, Dr. von Hauner Children's Hospital, University Hospital, Ludwig, Ludwig-Maximilians-Universität (LMU), München, Germany.

Enitan D Carrol (ED)

Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.
Alder Hey Children's NHS Foundation Trust, Liverpool, United Kingdom.

Juan Emmanuel Dewez (JE)

Faculty of Tropical and Infectious Disease, London School of Hygiene and Tropical Medicine, London, United Kingdom.

Marieke Emonts (M)

Great North Children's Hospital, Paediatric Immunology, Infectious Diseases & Allergy, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
NIHR Newcastle Biomedical Research Centre Based at Newcastle upon Tyne Hospitals NHS Trust and Newcastle University, Newcastle upon Tyne, United Kingdom.

Michiel van der Flier (M)

Pediatric Infectious Diseases and Immunology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands.
Pediatric Infectious Diseases and Immunology, Amalia Children's Hospital, Radboud University Medical Center, Nijmegen, The Netherlands.
Department of Laboratory Medicine, Section Pediatric Infectious Diseases, Laboratory of Medical Immunology, Radboud Institute for Molecular Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.

Ronald de Groot (R)

Stichting Katholieke Universiteit, Radboudumc Nijmegen, Nijmegen, The Netherlands.

Jethro Herberg (J)

Section of Paediatric Infectious Diseases, Imperial College of Science, Technology and Medicine, London, United Kingdom.

Benno Kohlmaier (B)

Department of General Paediatrics, Medical University of Graz, Graz, Austria.

Emma Lim (E)

Great North Children's Hospital, Paediatric Immunology, Infectious Diseases & Allergy, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.

Federico Martinon-Torres (F)

Genetics, Vaccines, Infections and Pediatrics Research Group (GENVIP), Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain.

Daan Nieboer (D)

Department of Public Health, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.

Ruud G Nijman (RG)

Section of Paediatric Infectious Diseases, Imperial College of Science, Technology and Medicine, London, United Kingdom.

Marko Pokorn (M)

Department of Infectious Diseases, University Medical Centre Ljubljana, Univerzitetni Klinični Center, Ljubljana, Slovenia.

Franc Strle (F)

Department of Infectious Diseases, University Medical Centre Ljubljana, Univerzitetni Klinični Center, Ljubljana, Slovenia.

Maria Tsolia (M)

Second Department of Paediatrics, National and Kapodistrian University of Athens, P. and A. Kyriakou Children's Hospital, Athens, Greece.

Clementien Vermont (C)

Department Pediatric Infectious Diseases & Immunology, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands.

Shunmay Yeung (S)

Faculty of Tropical and Infectious Disease, London School of Hygiene and Tropical Medicine, London, United Kingdom.

Dace Zavadska (D)

Department of Pediatrics, Rīgas Stradiņa Universitāte, Children Clinical University Hospital, Riga, Latvia.

Werner Zenz (W)

Department of General Paediatrics, Medical University of Graz, Graz, Austria.

Michael Levin (M)

Section of Paediatric Infectious Diseases, Imperial College of Science, Technology and Medicine, London, United Kingdom.

Henriette A Moll (HA)

Department of General Paediatrics, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH